ICVTS Click here to goto Smart Canula website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Adrian Levine
Joel Dunning
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thiagarajamurthy, S.
Right arrow Articles by Dunning, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thiagarajamurthy, S.
Right arrow Articles by Dunning, J.
Related Collections
Right arrow Cardiac - pharmacology
Right arrow Cardiac - other
Right arrow Education
Interactive Cardiovascular and Thoracic Surgery 3:489-494(2004)
© 2004 European Association of Cardio-Thoracic Surgery

Best evidence topic - Cardiac general

Does prophylactic tranexamic acid safely reduce bleeding without increasing thrombotic complications in patients undergoing cardiac surgery?

Sundaramoorthi Thiagarajamurthya, Adrian Levinea and Joel Dunningb,*

a Department of Cardiothoracic Surgery, North Staffordshire Royal Infirmary, Stoke, UK
b Department of Cardiothoracic Surgery, Freeman Hospital, Newcastle-upon-Tyne NE7 7DN, UK

moorti{at}hotmail.com

adrian_levine{at}hotmail.com

* Corresponding author. Tel.: +44-780-1548122
joeldunning{at}doctors.org.uk

A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether prophylactic tranexamic acid can safely reduce bleeding without increasing thrombotic complications in patients undergoing cardiac surgery. Altogether 334 papers were found using the reported search, of which 12 represented the best evidence on this topic. The author, journal, date and country of publication, patient group studied, study type, relevant outcomes, results, and study weaknesses were tabulated. We conclude that tranexamic acid clearly reduces blood loss, requirement for blood transfusion, and the risk of reoperation for bleeding, and although no study has yet looked directly at vein graft patency with tranexamic acid, no randomized studies have raised concerns over its safety.

Key Words: Evidence-based medicine; Tranexamic acid; Thoracic surgery; Cardiopulmonary bypass; Post-operative complications; Review

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 European Association for Cardio-thoracic Surgery